NGNina E de Groot

Nina E de Groot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nina E de Groot has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Clara C Elbers

    Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine Amsterdam UMC Location University of Amsterdam Amsterdam The Netherlands

    1 shared publication
  • Jarom Heijmans

    Affiliations Amsterdam UMC, University of Amsterdam, department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands, Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands, Amsterdam Gastroenterology Endocrinology and Metabolism institute, Amsterdam, The Netherlands

    1 shared publication
  • Lisanne E. Nijman

    Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands

    1 shared publication
  • Louis Vermeulen

    Laboratory of Experimental Oncology and Radiobiology, Cancer Center Amsterdam, Amsterdam UMC and University of Amsterdam, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands

    1 shared publication
  • Milou S. van Driel

    Amsterdam UMC, location University of Amsterdam, Laboratory for Experimental Oncology and Radiobiology, van der Boechorststraat 6b, 1081BT, Amsterdam, The Netherlands

    1 shared publication
  • Nicolas Léveillé

    Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Intestinal Apc‐inactivation induces HSP25 dependency

    by Sanne M van Neerven, Wouter L Smit, Milou S van Driel, Vaishali Kakkar, Nina E de Groot, Lisanne E Nijman, Clara C Elbers, Nicolas Léveillé, Jarom Heijmans, Louis Vermeulen

    The majority of colorectal cancers (CRCs) present with early mutations in tumor suppressor gene APC. APC mutations result in oncogenic activation of the Wnt pathway, which is associated with hyperproliferation, cytoskeletal remodeling, and a global increase in mRNA translation. To compensate for the increased biosynthetic demand, cancer cells critically depend on protein chaperones to maintain proteostasis, although their function in CRC remains largely unexplored. In order to investigate the role of molecular chaperones in driving CRC initiation, we captured the transcriptomic profiles of murine wild type and Apc‐mutant organoids during active transformation. We discovered a strong transcriptional upregulation of Hspb1, which encodes small heat shock protein 25 (HSP25). We reveal an indispensable role for HSP25 in facilitating Apc‐driven transformation, using both in vitro organoid cultures and mouse models, and demonstrate that chemical inhibition of HSP25 using brivudine reduces the development of premalignant adenomas. These findings uncover a hitherto unknown vulnerability in intestinal transformation that could be exploited for the development of chemopreventive strategies in high‐risk individuals.